Novartis breast cancer drug Kisqali wins EU approval

24th August 2017 Uncategorised 0

Novartis has announced the launch of its new breast cancer drug Kisqali in the UK today following a green light from European regulators.

More: Novartis breast cancer drug Kisqali wins EU approval
Source: News